XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Statement of Consolidated Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash Flows From Operating Activities    
Net income (loss) $ (1,306) $ (1,178)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gains on asset sales, net (276) (27)
Depreciation, depletion and amortization 2,237 2,476
Impairment 2,503 0
Exploratory dry hole costs 0 234
Exploration lease and other impairment 22 33
Stock compensation expense 65 69
Provision (benefit) for deferred income taxes and other tax accruals (2,055) (973)
Loss on debt extinguishment 0 80
Changes in operating assets and liabilities    
(Increase) decrease in accounts receivable (45) 278
(Increase) decrease in inventories (48) 1
Increase (decrease) in accounts payable and accrued liabilities (189) (266)
Increase (decrease) in taxes payable 3 (28)
Changes in other operating assets and liabilities (309) (230)
Net cash provided by (used in) operating activities 602 469
Cash Flows From Investing Activities    
Additions to property, plant and equipment - E&P (1,275) (1,575)
Additions to property, plant and equipment - Midstream (108) (189)
Proceeds from asset sales 783 80
Other, net (1) 18
Net cash provided by (used in) investing activities (601) (1,666)
Cash Flows From Financing Activities    
Net borrowings (repayments) of debt with maturities of 90 days or less 15 (14)
Debt with maturities of greater than 90 days – Borrowings 0 1,496
Debt with maturities of greater than 90 days – Repayments (107) (806)
Proceeds from issuance of Hess Midstream Partnership LP units 366 0
Proceeds from issuance of preferred stock 0 557
Proceeds from issuance of common stock 0 1,087
Cash dividends paid (273) (260)
Noncontrolling interests, net (208) 0
Other, net 0 (50)
Net cash provided by (used in) financing activities (207) 2,010
Net Increase (Decrease) in Cash and Cash Equivalents (206) 813
Cash and Cash Equivalents at Beginning of Year 2,732 2,716
Cash and Cash Equivalents at End of Period $ 2,526 $ 3,529